Vav-promoter regulated oncogenic fusion protein NPM-ALK in transgenic mice causes B-cell lymphomas with hyperactive Jun kinase

Oncogene

Volumn 22, Issue 49, 2003, Pages 7750-7761

  Turner, Suzanne D ^a   Tooze, Reuben ^b   Maclennan, Kenneth ^b   Alexander, Denis R ^a  

^a BABRAHAM INSTITUTE   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Jun kinase; Lymphoma; Mouse model; NPM ALK

Indexed keywords

HYBRID PROTEIN; IMMUNOGLOBULIN M; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN SHC; PROTEIN TYROSINE KINASE INHIBITOR; STRESS ACTIVATED PROTEIN KINASE; VAV PROTEIN;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; B CELL LYMPHOMA; CELL LINEAGE; CELL SPECIFICITY; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; GENE CONTROL; HEMATOPOIESIS; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; ONCOGENE; ONSET AGE; PHENOTYPE; PHYSIOLOGY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TRANSGENIC MOUSE;

ANIMALS; CELL LINE, TUMOR; CELL LINEAGE; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LYMPHOMA, B-CELL; MICE; MICE, TRANSGENIC; MITOGEN-ACTIVATED PROTEIN KINASES; ONCOGENE PROTEINS; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS C-VAV;

ANIMALIA; MUS MUSCULUS;

EID: 0344441893     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207048     Document Type: Article

References (56)

1. Bai RY, Dieter P, Peschel C, Morris SW and Duyster J. (1998). Mol. Cell. Biol., 18, 6951-6961.
2. Bai RY. Ouyang T, Miething C, Morris SW, Peschel C and Duyster J. (2000). Blood, 96, 4319-4327.
3. Benharroch D, MeguerianBedoyan Z, Lamant L, Amin C, Brugieres L, TerrierLacombe MJ, Haralambieva E, Pulford K, Pileri S, Morris SW, Mason DY and Delsol G. (1998). Blood, 91, 2076-2084.
4. Bischof D, Pulford K, Mason DY and Morris SW. (1997). Mol. Cell. Biol., 17, 2312-2325.
5. Bost F, McKay R, Bost M, Potapova O, Dean NM and Mercola D. (1999). Mol. Cell. Biol., 19, 1938-1949.
6. Chan PK, Chan FY, Morris SW and Xie Z. (1997). Nucleic Acids Res., 25, 1225-1232.
7. Chiarle R, Gong JZ, Guasparri L, Pesci A, Cai J, Liu J, Simmons WJ, Dhall G, Howes J, Piva R and Inghirami G. (2003). Blood, 101, 1919-1927.
8. Corcoran AE, Riddell A, Krooshoop D and Venkitaraman AR. (1998). Nature, 391, 904-907.
9. Davis RJ. (2000). Cell, 103, 239-252.
10. Delsol G, Lamant L, Mariame B, Pulford K, Dastugue N, Brousset P, RigalHuguet F, AlSaati T, Cerretti DP, Morris SW and Mason DY. (1997). Blood, 89, 1483-1490.
11. Dickens M, Rogers JS, Cavavagh J, Raitano A, Xia Z, Halpern JR, Greenberg ME, Sawyers CL and Davis RJ. (1997). Science, 277, 693-696.
12. Duyster J, Bai RY and Morris SW. (2001). Oncogene, 20, 5623-5637.
13. Eferl R, Ricci B, Kenner L, Zenz R, David JP, Rath M and Wagner EF. (2003). Cell, 112, 181-192.
14. Ehlich A, Martin V, Muller W and Rajewsky K. (1994). Curr. Biol., 4, 573-583.
15. Falini B and Mason DY. (2002). Blood, 99, 409-426.
16. Falini B, Pulford K, Pucciarini A, Carbone A, De Wolf-Peeters C, Cordell J, Fizzotti M, Santucci A, Pelicci PG, Pileri S, Campo E, Ott G, Delsol G and Mason DY. (1999). Blood, 94, 3509-3515.
17. Fujimoto J, Shiota M, Iwahara T, Seki N, Satoh H, Mori S and Yamamoto T. (1996). Proc. Natl. Acad. Sci. USA, 93, 4181-4186.
18. Gascoyne RD, Aoun P, Wu D, Chhanabhai M, Skinnider BF, Greiner TC, Morris SW, Connors JM, Vose JM, Viswanatha DS, Coldman A and Weisenburger DD. (1999). Blood, 93, 3913-3921.
19. Greenland C, Touriol C, Chevillard G, Morris SW, Bai R, Duyster J, Delsol G and Allouche M. (2001). Oncogene, 20, 7386-7397.
20. Hardy RR and Hayakawa K. (2001). Annu. Rev. Immunol., 19, 595-621.
21. Hariharan IK, Harris AW, Crawford M, Abud H, Webb E, Cory S and Adams JM. (1989). Mol. Cell. Biol., 9, 2798-2805.
22. Hess P, Pihan G, Sawyers CL, Flavell R and Davis RJ. (2002). Nat. Genet., 32, 201-205.
23. Hestdal K, Ruscetti FW, Ihle JN, Jacobsen SE, Dubois CM, Kopp WC, Longo DL and Keller JR. (1991). J. Immunol., 147, 22-28.
24. Iwahara T, Fujimoto J, Wen DZ, Cupples R, Bucay N, Arakawa T, Mori S, Ratzkin B and Yamamoto T. (1997). Oncogene, 14, 439-449.
25. Jaffe ES, Harris NL, Stein H and Vardiman JW (eds) (2001). Tumours of Haematopoietic and Lymphoid Tissue. IARC: Lyon.
26. Johnson R, Spiegelman B, Hanahan D and Wisdon R. (1996). Mol. Cell. Biol. 16, 4504-4511.
27. Kanda M, Suzumiya J, Ohshima K, Okada M, Tamura K and Kikuchi M. (2001). Leuk. Lymphoma, 42, 639-647.
28. Katsura Y. (2002). Nat. Rev. Immunol., 2, 127-132.
29. Kuefer MU, Look AT, Tripp R, Behm FG, Pattengale PK and Morris SW. (1997). Blood, 90, 2901-2910.
30. Lamb JA, Ventura J-J, Hess P, Flavell RA and Davis RJ. (2003). Mol. Cell, 11, 1479-1489.
31. Kennedy NJ and Davis RJ. (2003). Cell Cycle, 2, 199-201.
32. Lanier LL and Hemperly JJ. (1995). Leucocyte Typing, V, 1398-1400.
33. Li YS, Wasserman R, Hayakawa K and Hardy RR. (1996). Immunity, 5, 527-535.
34. Maes B, Anastasopoulou A, Kluin-Nelemans JC, Teodorovic I, Achten R, Carbone A and De Wolf-Peeters C. (2001). Ann. Oncol., 12, 853-858.
35. Mason DY, Pulford KAF, Bischof D, Kuefer MU, Butler LH, Lamant L, Delsol G and Morris SW. (1998). Cancer Res., 58, 1057-1062.
36. Morris SW, Kirstein MN, Valentine MB, Dittmer KG, Shapiro DN, Saltman DL and Look AT. (1994). Science, 263, 1281-1284.
37. Morris SW, Naeve C, Mathew P, James PL, Kirstein MN, Cui XL and Witte DP. (1997). Oncogene, 14, 2175-2188.
38. Morris SW, Naeve C, Mathew P, Kirstein MN, Cui XL and Witte DP. (1995). Blood, 86, 647.
39. Morris SW, Xue L, Ma Z and Kinney MC. (2001). Br. J. Haematol, 113, 275-295.
40. Ogilvy S, Metcalf D, Gibson L, Bath ML, Harris AW and Adams JM. (1999a). Blood, 94, 1855-1863.
41. Ogilvy S, Metcalf D, Print CG, Bath ML, Harris AW and Adams JM. (1999b). Proc. Natl. Acad. Sci. USA, 96, 14943-14948.
42. Ogilvy S, Louis-Dit-Sully C, Cassady RL, Alexander DR and Holmes N. (2003). J. Immunol., 171, 1792-1800.
43. Onciu M, Behm FG, Downing JR, Shurtleff SA, Raimondi SC, Ma Z, Morris SW, Kennedy W, Jones SC and Sandlund JT. (2003). Blood, in press.
44. Peek Jr RM and Blaser MJ. (2002). Nat. Rev. Cancer, 2, 28-37.
45. Potapova O, Gorospe M, Dougherty RH, Dean NM, Gaarde WA and Holbrdok NJ. (2000). Mol. Cell. Biol., 20, 1713-1722.
46. Pulford K, Lamant L, Morris SW, Butler LH, Wood KM, Stroud D, Delsol G and Mason DY. (1997). Blood, 89, 1394-1404.
47. Rabbitts TH. (1998). N. Engl. J. Med, 338, 192-194.
48. Sanderson D and Borset M. (2002). Ann. Hematol., 81, 125-135.
49. Schreiber M, Kolbus A, Piu F, Szabowski A, Mohle-Steinlein U, Tian J, Karin M, Angel P and Wagner EF. (1999). Genes Dev., 13, 607-619.
50. Sebestyen A, Berczi L, Mihalik R, Paku S, Matolcsy A and Kopper L. (1999). Br. J. Haematol, 104, 412-419.
51. Stewart M, Cameron E, Campbell M, McFarlane R, Toth S, Lang K, Onions D and Neil JC. (1993). Int. J. Cancer, 53, 1023-1030.
52. ten Boekel E, Melchers F and Rolink A. (1995). Int. Immunol., 7, 1013-1019.
53. Weisenburger DD, Anderson JR, Diebold J, Gascoyne RD, MacLennan KA, Muller-Hermelink HK, Nathwani BN, Ullrich F and Armitage JO. (2001). Am. J. Hematol., 67, 172-178.
54. Yang YM, Bost F, Charbono W, Dean N, McKay R, Rhim JS, Depatie C and Mercola D. (2003). Clin. Cancer Res., 9, 391-401.
55. Zhumabekov T, Corbella P, Tolaini M and Kioussis D. (1995). J. Immunol. Methods, 185, 133-140.
56. Zukerberg LR, Collins AB, Ferry JA and Harris NL. (1991). Am. J. Pathol., 139, 475-483.